Cronos Group is a BUY, say Stifel analyst

Stifel analyst Andrew Carter upgraded Cronos Group to Buy from Hold with a price target of…

Cronos Group to Buy American Hemp CBD Assets for $300 Million

TORONTO, Aug. 02, 2019 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”…

Canopy And Cronos Are Exposed Come Earnings

Summary Growth of sales of recreational cannabis might be modest comparing Q1’19 to Q4’19. CRON is…